Reuters/Gary CameronAs scrutiny of high drug prices in the US intensifies, so has the finger pointing about who is to blame. This week, that came in the form of an interview in which an executive at Gilead blamed high prices on pharmacy benefit managers, the companies that help insurance plans determine what drugs they'll cover and how much they'll pay.

BING NEWS:
  • 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
    A major metric of competition in generic business is pricing, which continues to face downward pressure. Apart from intense regulatory pressure on drug quality and manufacturing, the generic drugs ...
    04/18/2024 - 4:12 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News